Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Papadimitriou C, Dafni U, Bafaloukos D, Skarlos D, Moulopoulos LA, Razis E, Kalofonos HP, Aravantinos G, Briassoulis E, Papakostas P, Abela K, Gogas E, Kosmidis P, Pavlidis N, Dimopoulos MA. Fountzilas G, et al. Among authors: kalofonos hp. J Clin Oncol. 2001 Apr 15;19(8):2232-9. doi: 10.1200/JCO.2001.19.8.2232. J Clin Oncol. 2001. PMID: 11304776 Clinical Trial.
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Skarlos DV, Samantas E, Briassoulis E, Panoussaki E, Pavlidis N, Kalofonos HP, Kardamakis D, Tsiakopoulos E, Kosmidis P, Tsavdaridis D, Tzitzikas J, Tsekeris P, Kouvatseas G, Zamboglou N, Fountzilas G. Skarlos DV, et al. Among authors: kalofonos hp. Ann Oncol. 2001 Sep;12(9):1231-8. doi: 10.1023/a:1012295131640. Ann Oncol. 2001. PMID: 11697833 Free article. Clinical Trial.
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G. Pectasides D, et al. Among authors: kalofonos hp. Anticancer Res. 2001 Jul-Aug;21(4B):3005-10. Anticancer Res. 2001. PMID: 11712802 Clinical Trial.
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP. Kosmas C, et al. Among authors: kalofonos hp. Cancer. 2001 Dec 1;92(11):2902-10. doi: 10.1002/1097-0142(20011201)92:11<2902::aid-cncr10103>;2-o. Cancer. 2001. PMID: 11753965 Clinical Trial.
267 results